Orgenesis Inc. Appoints Biotech Veteran to Board of DirectorsMarketWatch (press release)The Company believes that converting the diabetic patient's own tissue into insulin-producing cells overcomes the problem of donor shortage and removes the risk…
Role of Screening, Monitoring in Early Kidney Disease Unclear – U.S. News & World Report
Role of Screening, Monitoring in Early Kidney Disease UnclearU.S. News & World ReportBy Serena Gordon TUESDAY, April 17 (HealthDay News) — At least one in 10 US adults is estimated to have chronic kidney disease, but whether screening and monitoring p…
Joe Huiras Benefit to be held April 28 – Sleepy Eye Herald Dispatch
Joe Huiras Benefit to be held April 28Sleepy Eye Herald DispatchA benefit is being held to raise money to help with medical bills for Joe's stem cell transplant which is scheduled to take place on May 7. Joe, a 2002 graduate of St. Mary's Schoo…
Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in … – MarketWatch (press release)
Pluristem Receives U.S. FDA Clearance for Phase II Clinical Trial in …MarketWatch (press release)… models have demonstrated PLX cells are also potentially effective for other ischemic and inflammatory indications such as heart disease, muscle injur…
Opsona Therapeutics announces the issuance of new patent from the European … – MarketWatch (press release)
Opsona Therapeutics announces the issuance of new patent from the European …MarketWatch (press release)TLR-2 plays an important role in the induction and progression of a number of non-pathogen associated inflammatory conditions including ischemia re…
ImmunoGen, Inc. Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its … – SunHerald.com
ImmunoGen, Inc. Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its …SunHerald.comToday NHL is frequently treated with the anticancer antibody, rituximab (Rituxan®), and/or with chemotherapy. The novel agent IMGN529, a TAP compound, conta…
IMMUNOGEN, INC. : Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its … – 4-traders
IMMUNOGEN, INC. : Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its …4-tradersToday NHL is frequently treated with the anticancer antibody, rituximab (Rituxan®), and/or with chemotherapy. The novel agent IMGN529, a TAP compound, contain…
ImmunoGen, Inc. Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its … – MarketWatch (press release)
ImmunoGen, Inc. Initiates Phase I Trial in Non-Hodgkin's Lymphoma with Its …MarketWatch (press release)Today NHL is frequently treated with the anticancer antibody, rituximab (Rituxan(R)), and/or with chemotherapy. The novel agent IMGN529, a TAP …
Rowan University Public Relations Student Society of America hosts Organ Donor … – Gloucester County Times – NJ.com
Gloucester County Times – NJ.comRowan University Public Relations Student Society of America hosts Organ Donor …Gloucester County Times – NJ.comBy Jessica Driscoll/ Gloucester County Times View full sizeJames Lavery of Mullica Hill, who had a liver t…
City to figure in transplant network
India will soon have an apex body under the National Organ Transplant Programme (NOTP) to ensure transparent and accountable multi-organ donation and transplant.The Centre has identified 15…